Get more fleet vehicle power, faster charging at idle with APS UPI alternators available in 48V, 24V and 12V models
DAVENPORT, Iowa, Aug. 25, 2025 /PRNewswire/ — American Power Systems, Inc. (APS) recently launched the Ultra Performance at Idle (UPI) series, its next-generation... Read more.
LivePerson Announces AWS Integration to Unify Voice and Digital Customer Experiences
CX leaders looking to improve agent retention while increasing self-service with lower cost-to-serve will benefit from the newly integrated CCaaS platform NEW YORK,... Read more.
WCG Reduces Clinical Trial Protocol Deviations by 35-50% with the Launch of Total Training, the First Comprehensive Solution for Improved Site Readiness, Engagement, and Compliance
CARY, N.C., Aug. 25, 2025 /PRNewswire/ — WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced... Read more.
Webull Launches Crypto Trading in U.S.
Users are now able to trade cryptocurrencies directly on the Webull platform NEW YORK, Aug. 25, 2025 /PRNewswire/ — Webull (NASDAQ: BULL), an online investment... Read more.
RSM Achieves CMMC Level 2 Certification as an External Service Provider for Government Contractors
CHICAGO, Aug. 25, 2025 /PRNewswire/ — RSM US LLP (“RSM”) – the leading provider of assurance, tax and consulting services for the middle market... Read more.
EcoFlow Unveils New Power Bank Lineups, Redefining How We Charge for Work, Travel and Life
RAPID Pro Series, RAPID Series and RAPID Mag Series offer on-the-go charging solutions for everyone, ranging from ultimate performance to ultra-slim, magnetic convenience... Read more.
Velo3D Participates in U.S. Army AvMC and M&S Program Funded Initiative to Advance High-Throughput Aluminum CP1 Additive Manufacturing for Defense Applications in Collaboration with RTX and Raytheon Technologies Research Center
FREMONT, Calif., Aug. 25, 2025 /PRNewswire/ — Velo3D, Inc. (Nasdaq: VELO), a leader in additive manufacturing (AM) technology known for transforming aerospace... Read more.
AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
Gilgamesh’s lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major... Read more.
Everest Medicines Announces Participation in September Investor Conferences
SHANGHAI, Aug. 25, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused... Read more.
PCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical Research
EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator™ to improve access for trial participants. DENVER,... Read more.